Prostate Cancer NEWS You Can Use  
 
Us TOO news e-messages
 Us TOO Prostate Cancer NEWS You Can Use

Cleveland Clinic discovers similarities between next-generation prostate cancer drugs
By a News Reporter-Staff News Editor at Clinical Trials Week -- Cleveland: Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for ...

Researchers develop new test to target prostate cancer treatment
By testing cancer DNA in the bloodstream, researchers from The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust, were also able to pick out patients not responding to treatment so that they could be switched to alternative therapy in just four to eight weeks. The test was also used to monitor a patients blood throughout treatment to quickly determine if ...

Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer
By a News Reporter-Staff News Editor at Cancer Weekly -- TAMPA, Fla. () - Prostate cancer is the third most common cause of cancer-related death in men in the United States. It is estimated that 161,360 men will be diagnosed and more than 26,700 men will die from the disease in this year. The majority of these deaths are caused by prostate cancer that becomes resistant to initial therapy and ...

Starving prostate cancer with what you eat for dinner
By a News Reporter-Staff News Editor at Cancer Weekly -- When you dine on curry and baked apples, enjoy the fact that you are eating something that could play a role starving -- or even preventing -- cancer (see also Oncology - Prostate Cancer). New research from The University of Texas at Austin identifies several natural compounds found in food, including turmeric, apple peels and red ...

Studies in the Area of Prostate Cancer Reported from National Cancer Institute (Management Options for Biochemically Recurrent Prostate Cancer)
By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news reporting originating from Bethesda, Maryland, by NewsRx correspondents, research stated, "Prostate cancer is the most common solid tumor malignancy in men worldwide. Treatment with surgery and radiation can be curative in organ-confined disease." ...

Tel Aviv University Reports Findings in Prostate Cancer (Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical...
Tel Aviv University Reports Findings in Prostate Cancer (Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?) By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting originating from Tel Aviv, Israel, by NewsRx correspondents, research stated, "The ...

Data on Prostate Cancer Described by Researchers at University of Toronto (Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme...
Data on Prostate Cancer Described by Researchers at University of Toronto (Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care - Cancer Care Ontario Clinical Practice Guideline) By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news originating from Toronto, ...

Prostate PET/CT targets more cancer and improves patient care
By a News Reporter-Staff News Editor at Clinical Trials Week -- DENVER, Colo. - An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific molecular imaging gives these men a fighting chance, especially if their cancer returns, according to research revealed at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging ...

New Prostate Cancer Study Results Reported from Cleveland Clinic (The present and future of prostate cancer histopathology)
By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Prostate Cancer is now available. According to news reporting out of Cleveland, Ohio, by NewsRx editors, the research stated, "The present review describes recent changes in the histologic grading of prostatic adenocarcinoma and emerging data suggesting areas for further grade optimization. The grading of ...

New blood test uses nanotechnology to predict aggressive prostate cancer accurately
By a News Reporter-Staff News Editor at Cancer Weekly -- A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to test for aggressive prostate cancer. The test incorporates a unique nanotechnology platform to make the diagnostic using only a single drop of blood, and is significantly more accurate than current screening methods (see also Oncology - Prostate ...

New three-in-one blood test opens door to precision medicine for prostate cancer
By a News Reporter-Staff News Editor at Cancer Weekly -- Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes (see also Oncology - Prostate Cancer). By testing cancer DNA in the bloodstream, researchers found they could pick out which men with advanced ...

First-of-its-kind blood test unlocks precision treatment options for prostate cancer
The three-in-one blood test was developed by teams at the Institute of Cancer Research (ICR) in London and can be used to find patients whom PARP inhibitors such as Lynparza could act most effectively on, and additionally monitor whether a patient is responding adequately to this treatment by checking the DNA in the blood. In the event that treatment is not successful, patients can be moved to ...

Reports Outline Prostate Cancer Study Findings from Thomas Jefferson University (PARP Inhibitors in Prostate Cancer)
By a News Reporter-Staff News Editor at Cancer Vaccine Week -- New research on Oncology - Prostate Cancer is the subject of a report. According to news reporting from Philadelphia, Pennsylvania, by NewsRx journalists, research stated, "The genomic landscape of metastatic prostate cancer (mPCa) reveals that up to 90% of patients harbor actionable mutations and 920% have somatic DNA repair gene ...

New Findings from Deakin University in the Area of Prostate Cancer Described (Cognitive decline in prostate cancer patients undergoing ADT: a...
New Findings from Deakin University in the Area of Prostate Cancer Described (Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training) By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting originating from Geelong, Australia, by NewsRx correspondents, ...

Research Conducted at Department of Urology Has Updated Our Knowledge about Prostate Cancer (Cognitive Function in Patients With Prostate Cancer...
Research Conducted at Department of Urology Has Updated Our Knowledge about Prostate Cancer (Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, ...) By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting out of ...

Investigators at Asan Medical Center Report Findings in Prostate Cancer (Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk...
Investigators at Asan Medical Center Report Findings in Prostate Cancer (Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk Prostate Cancer and its Relationship with Anatomical Location of Tumor) By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting originating from Seoul, South ...

Abiraterone delays metastatic prostate cancer growth by 18 months, extends survival
By a News Reporter-Staff News Editor at Clinical Trials Week -- ASCO Perspective "For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone," said Sumanta Kumar Pal, MD, ASCO Expert. "This is good news because using abiraterone could help many people live longer with fairly few additional side ...

Abiraterone slows advanced prostate cancer, helps patients live longer
By a News Reporter-Staff News Editor at Clinical Trials Week -- ASCO Perspective "This study provides strong evidence to support adding abiraterone to standard hormone therapy, primarily for men with metastatic prostate cancer," said Sumanta Kumar Pal, MD, ASCO Expert. "It adds to a growing body of evidence that establishes abiraterone as a standard of care in this setting." CHICAGO - A ...

Study Findings from Yale University Broaden Understanding of Prostate Cancer (Active Surveillance in Younger Men With Prostate Cancer)
By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Prostate Cancer are discussed in a new report. According to news reporting originating in New Haven, Connecticut, by NewsRx journalists, research stated, "PurposeThe suitability of younger patients with prostate cancer (PCa) for initial active surveillance (AS) has been questioned on the basis of eventual ...

Study Results from Massachusetts General Hospital Broaden Understanding of Prostate Cancer (Clinical Outcomes from Androgen Signaling-directed...
Study Results from Massachusetts General Hospital Broaden Understanding of Prostate Cancer (Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic ...) By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting out of ...

Data from Huazhong University of Science and Technology Advance Knowledge in Prostate Cancer (Calpain and AR-V7: Two potential therapeutic targets to...
Data from Huazhong University of Science and Technology Advance Knowledge in Prostate Cancer (Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells) By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting ...

Higher Prostate Cancer Risks for Black Men May Warrant New Approach to Screening
A new study indicates that higher prostate cancer death rates among black men in the United States may be due to a higher risk of developing preclinical prostate cancer as well as a higher risk of that cancer progressing more quickly to advanced stages.1 The study suggests that screening policies may need to be tailored to the higher-risk status of this population. Among black men in the ...

GenomeDx Announces New York State CLEP Approval of Decipher Prostate Cancer Tests
By a News Reporter-Staff News Editor at Drug Week -- GenomeDx Biosciences, a leader in the field of urologic cancer genomics, announced approval by the New York State Clinical Laboratory Evaluation Program (CLEP) of GenomeDx's prostate cancer classifier tests, Decipher® Biopsy and Decipher Post-Op, which are genomic tests intended to improve clinical decision-making following biopsy or radical ...

Chinese company completes acquisition of US firm providing immunotherapy for prostate cancer
SAN FRANCISCO - Sanpower Group, a private Chinese conglomerate, announced Friday the completion of its acquisition of Dendreon, from Valeant Pharmaceuticals International, Inc for $819.9 million in cash. At the heart of the deal is Dendreon's lead product, Provenge, the only cellular immunotherapy approved so far by the US Food and Drug Administration (FDA) for treatment of asymptomatic or ...

How Did It Go? Ghanaian Men Experience With Prostate Cancer and Sex Life - Ghana Prostate Cancer Research Findings
How did your treatment go with prostate cancer? What were your fears and challenges after conventional prostate cancer treatment? Did you receive any post treatment support from your cancer team? Did the Doctor spare your prostate erection nerves? What type of treatment did you received from your Doctor? Did you even understand the treatment regime before you accepted the treatment? Were you ...

Researchers at University of California Report New Data on Prostatectomy (Individual Patient-Level Meta-Analysis of the Performance of the Decipher...
Researchers at University of California Report New Data on Prostatectomy (Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic ...) By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Fresh data on Surgery - Prostatectomy are presented in a new report. According ...

Genes may cause tumor aggressiveness and drug resistance in African-American prostate cancer
By a News Reporter-Staff News Editor at Cancer Weekly -- WASHINGTON () -- A form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer. Researchers at the George Washington University (GW) Cancer Center published their findings in Nature Communications (see also Oncology - Prostate ...

‘Short-fingered’ docs skip prostate probes
Digital rectal examination is up to 68% accurate in early diagnosis of men without symptoms LESS than one in seven doctors examines the prostate gland for cancer, with excuses including “My finger is too short”. Other reasons given for not performing a digital rectal examination include: “It might be taken as sexual harassment”, “There’s no privacy in the ward” and “There’s no lubricant”. ...

Study: New blood test is more accurate in predicting prostate cancer risk than PSA
By a News Reporter-Staff News Editor at Clinical Trials Week -- A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures - distinguishing cancer from benign conditions, and ...

New blood test predicts who will benefit from targeted prostate cancer treatments
By a News Reporter-Staff News Editor at Clinical Trials Week -- A new blood test could predict which men with advanced prostate cancer will respond to new targeted treatments for the disease (see also Oncology - Prostate Cancer). Researchers were able to detect tumour DNA in men's blood and pick out cancers with multiple copies of the androgen receptor gene, which many prostate cancers rely on ...

Early MRI may lower costs for prostate cancer treatment
By a News Reporter-Staff News Editor at Biotech Week -- A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center. Researchers compared MR-guided approaches to the current standard of transrectal ...

New Prostate Cancer Study Findings Have Been Reported by Researchers at Washington University (Determination of the Role of Negative Magnetic...
New Prostate Cancer Study Findings Have Been Reported by Researchers at Washington University (Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary?) By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Prostate Cancer are discussed in a new report. According to news originating from ...

New Findings in Prostate Cancer Described from Monash University (Cabazitaxel in patients with metastatic castration-resistant prostate cancer:...
New Findings in Prostate Cancer Described from Monash University (Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program) By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news originating from Melbourne, Australia, by ...

Investigators from Stanford University Have Reported New Data on Prostate Cancer (Genome-wide DNA methylation measurements in prostate tissues...
Investigators from Stanford University Have Reported New Data on Prostate Cancer (Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns) By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news originating from ...

Recent Findings from W.N. Brennen and Co-Researchers Yields New Information on Prostate Cancer (Mesenchymal stem cell infiltration during neoplastic...
Recent Findings from W.N. Brennen and Co-Researchers Yields New Information on Prostate Cancer (Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate) By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting out of Baltimore, Maryland, by NewsRx editors, research ...

Data on Prostate Cancer Detailed by Researchers at Hiroshima University Institute of Biomedical and Health Sciences (Body mass index as a classifier...
Data on Prostate Cancer Detailed by Researchers at Hiroshima University Institute of Biomedical and Health Sciences (Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower ...) By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting ...

Studies from Tufts University School of Medicine Yield New Information about Prostate Cancer (The 4Kscore blood test accurately identifies men with...
Studies from Tufts University School of Medicine Yield New Information about Prostate Cancer (The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information) By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating in ...

New Prostate Cancer Study Results from University of British Columbia Described (Evaluating an educational intervention to alleviate distress amongst...
New Prostate Cancer Study Results from University of British Columbia Described (Evaluating an educational intervention to alleviate distress amongst men with newly diagnosed prostate cancer and their partners) By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting originating from Vancouver, ...

New Prostate Cancer Findings from University of California Reported (Impact of the United States Preventive Services Task Force 'D' recommendation on...
New Prostate Cancer Findings from University of California Reported (Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging) By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Prostate Cancer is the subject of a report. According to news reporting out of San Francisco, California, by NewsRx ...

Studies from S. Loeb and Colleagues Reveal New Findings on Prostate Cancer (The role of prostate cancer biomarkers in undiagnosed men)
By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Prostate Cancer are presented in a new report. According to news originating from New York City, New York, by NewsRx correspondents, research stated, "This article intends to review biomarkers derived from blood, urine, and tissue that can aid in the diagnosis of prostate cancer (PCa). PCa screening requires ...

Recent Findings from University of Pennsylvania School of Medicine Has Provided New Data on Prostate-Specific Antigen (Association between features...
Recent Findings from University of Pennsylvania School of Medicine Has Provided New Data on Prostate-Specific Antigen (Association between features of patient-provider discussions and routine prostate-specific antigen testing) By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Enzymes and Coenzymes - Prostate-Specific Antigen have been published. According ...

Data from Department of Radiology Advance Knowledge in Prostate Cancer (Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing...
Data from Department of Radiology Advance Knowledge in Prostate Cancer (Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing or the sheep in wolf's clothing?) By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Prostate Cancer is now available. According to news originating from Amsterdam, Netherlands, by NewsRx correspondents, research ...

Research Conducted at University of Colorado Has Provided New Information about Prostate Cancer (Abiraterone acetate and prednisone in...
Research Conducted at University of Colorado Has Provided New Information about Prostate Cancer (Abiraterone acetate and prednisone in chemotherapy-na?ve prostate cancer patients: rationale, evidence and clinical utility) By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting originating in ...

Studies from King's College London Have Provided New Data on Prostate Cancer (Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events)
By a News Reporter-Staff News Editor at Drug Week -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting originating in London, United Kingdom, by NewsRx journalists, research stated, "To investigate the risk of thromboembolic disease (TED) after radiation therapy (RT) with curative intent for prostate cancer (PCa). We identified all men who ...

Findings from University of Manitoba Reveals New Findings on Prostate Cancer (Filtration-based enrichment of circulating tumor cells from all...
Findings from University of Manitoba Reveals New Findings on Prostate Cancer (Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups) By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Prostate Cancer is now available. According to news reporting originating from Winnipeg, Canada, by NewsRx correspondents, research stated, ...

Data on Prostate Cancer Reported by Researchers at New York University (Role of MRI prebiopsy in men at risk for prostate cancer: taking off the...
Data on Prostate Cancer Reported by Researchers at New York University (Role of MRI prebiopsy in men at risk for prostate cancer: taking off the blindfold) By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Oncology - Prostate Cancer. According to news reporting from New York City, New York, by NewsRx journalists, research stated, "We review recent ...

New Findings from Tom Baker Cancer Center Describe Advances in Prostate Cancer (Dynamics of three-dimensional telomere profiles of circulating tumor...
New Findings from Tom Baker Cancer Center Describe Advances in Prostate Cancer (Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are under going androgen deprivation and ...) By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Prostate Cancer have been published. According to news ...

GenomeDx's Decipher GRID Aids in Development and Validation of Molecular Subtypes in Prostate Cancer that Predict Response to Hormone Therapy
By a News Reporter-Staff News Editor at Information Technology Newsweekly -- GenomeDx Biosciences, a leader in the field of urologic cancer genomics, announced that a genomic signature commonly used with breast cancer patients to determine their risk of recurrence has been found to also identify which patients with aggressive prostate cancer may benefit from hormone therapy. Using gene ...

Researchers from Department of Urology Describe Findings in Prostate Cancer (Identification and evaluation of clinically significant prostate cancer:...
Researchers from Department of Urology Describe Findings in Prostate Cancer (Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis) By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting out of Salford, United Kingdom, by NewsRx editors, ...

A potential cure for metastatic prostate cancer? Treatment combination shows early promise
By a News Reporter-Staff News Editor at Clinical Trials Week -- Philadelphia, PA, In the past, all forms of metastatic prostate cancer have been considered incurable. In recent years, the FDA has approved six drugs for men with metastatic disease, all of which can increase survival. In a study published in Urology®, researchers demonstrate for the first time that an aggressive combination of ...

 
 

Facebook - UsToo.org  Twitter - UsToo.org  LinkedIn - UsToo.org Inspire prostate cancer discussions – UsToo.org 

Contact Us | Privacy Policy | Terms & Conditions | Disclaimer   

 
Copyright © 2005-2017 Us TOO International, Inc.
Designed and hosted by ACCESS Medical Group, Ltd.